Literature DB >> 4148502

Antibronchoconstrictor activity of two new phosphodiesterase inhibitors, a triazolopyrazine (ICI 58 301) and a triazolopyrimidine (ICI 63 197).

G E Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4148502     DOI： 10.1111/j.2042-7158.1973.tb10048.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

Review 1.  On the action of combination bronchodilators.

Authors:  C J Hanna; P Eyre
Journal:  Agents Actions       Date:  1979-10

2.  The insulin- and glucagon-stimulated 'dense-vesicle' high-affinity cyclic AMP phosphodiesterase from rat liver. Purification, characterization and inhibitor sensitivity.

Authors:  N J Pyne; M E Cooper; M D Houslay
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

3.  Interactions between the effects of alpha- and beta-adrenoceptor agonists and adenine nucleotides on the membrane potential of cells in guinea-pig liver slices.

Authors:  D H Jenkinson; K Koller
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

4.  Microiontophoretic studies of the effects of cylic nucleotides on excitability of neurones in the rat cerebral cortex.

Authors:  T W Stone; D A Taylor
Journal:  J Physiol       Date:  1977-04       Impact factor: 5.182

5.  Purine antagonists in the identification of adenosine-receptors in guinea-pig trachea and the role of purines in non-adrenergic inhibitory neurotransmission.

Authors:  R A Coleman
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

6.  Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).

Authors:  D P Evans; D S Thomson
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

7.  Differentiation of intestinal smooth muscle relaxation caused by drugs that inhibit phosphodiesterase.

Authors:  G Pöch; W Umfahrer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-06       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.